Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...

Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu ...

For patients with chronic pain who wish to minimize the use of medications or more invasive procedures, physicians at the University of Alabama at Birmingham Pain Treatment Clinic at UAB ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc (“Nalu”) is a Carlsbad, California-based company that has successfully miniaturized neurostimulation implants for the management of chronic ...

Pendergrast is an anesthesiology resident physician at the University of Michigan. The 1 in 5 Americans suffering from chronic pain may soon lose access to evidence-based interventions that have ...

Electrical stimulation was delivered by an external stimulator (top left) through percutaneous leads to FINEs implanted on the median, ulnar, and radial nerves of an upper-limb amputee (bottom left).

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...